EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Apigenin and Placental β‐Endorphin Signaling: A Hypothesis‐Generating Mechanistic Review

Bipasha Goswami iD, Tushar Adhikari iD, Snigdha Das

American Journal of Reproductive Immunology · 2026-11 · 96 (5)

DOI: 10.1111/aji.70341 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 30.10.2026. Verfasst von Bipasha Goswami und 2 weiteren Autor:innen. Beteiligte Einrichtung: Guru Nanak Institute of Pharmaceutical Science and Technology, Kolkata, West Bengal, India. Hauptthemen laut MEDLINE: Placenta, Apigenin, beta-Endorphin. Die Arbeit nennt 115 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The placenta functions as a dynamic endocrine hub that translates maternal exposures into offspring developmental programming, consistent with the Developmental Origins of Health and Disease (DOHaD) framework. Beta‐endorphin (β‐EP), a placental POMC‐derived opioid peptide, signals through MOR/DOR/KOR receptors to regulate angiogenesis, immune tolerance, oxidative stress, inflammation, and nutrient transport. Apigenin, a dietary flavone found in parsley, chamomile, and celery, modulates several pathways that overlap with this axis, including CREB/PKA signaling, DNA methyltransferase activity, Nrf2, NF‐κB/NLRP3, and Foxp3 + Treg differentiation, although most supporting evidence derives from non‐placental systems such as cancer lines, keratinocytes, and macrophages. This review proposes that apigenin may amplify placental β‐EP signaling across three conceptual tiers: a biosynthetic tier involving CREB/PKA‐mediated POMC activation and 11β‐HSD1 inhibition; a receptor‐level tier involving DNMT1/3a inhibition and OPRM1 demethylation; and an effector‐level tier involving Nrf2 activation, NF‐κB/NLRP3 suppression, and Treg expansion, the last representing the strongest trophoblast‐level evidence. Given reported β‐EP dysregulation in preeclampsia, gestational diabetes, preterm birth, and intrauterine growth restriction, apigenin's relevance to these disorders remains an untested hypothesis rather than a validated therapeutic strategy, informed by a structured, non‐systematic literature search (1986–2026).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlacentaApigeninbeta-EndorphinHumansPregnancySignal TransductionFemaleAnimalsDevelopmental Origins of Health and Disease

Stichwörter der Autor:innen

DOHaDIUGRapigeninflavonoidgut microbiotahypothesis‐generating reviewmaternal‐fetal programming

Substanzen

Apigeninbeta-Endorphin

Autor:innen und Institutionen

  • Guru Nanak Institute of Pharmaceutical Science and Technology, Kolkata, West Bengal, India.
  • Surendralal Das Teachers Training College, Kolkata, West Bengal, India.

ORCID-Profile: Bipasha Goswami, Tushar Adhikari

Zitieren

APA

Goswami, B., Adhikari, T., & Das, S. (2026). Apigenin and Placental β‐Endorphin Signaling: A Hypothesis‐Generating Mechanistic Review. American Journal of Reproductive Immunology, 96(5). https://doi.org/10.1111/aji.70341

Vancouver

Goswami B, Adhikari T, Das S. Apigenin and Placental β‐Endorphin Signaling: A Hypothesis‐Generating Mechanistic Review. American Journal of Reproductive Immunology. 2026;96(5). doi:10.1111/aji.70341

BibTeX
@article{Goswami2026,
  author = {Goswami, Bipasha and Adhikari, Tushar and Das, Snigdha},
  title = {Apigenin and Placental β‐Endorphin Signaling: A Hypothesis‐Generating Mechanistic Review},
  journal = {American Journal of Reproductive Immunology},
  year = {2026},
  volume = {96},
  number = {5},
  doi = {10.1111/aji.70341}
}
Kostenlos starten →